Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Aug 16;91(17):8005–8009. doi: 10.1073/pnas.91.17.8005

A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitis.

D J Topham 1, B Nag 1, S Arimilli 1, S Sriram 1
PMCID: PMC44533  PMID: 8058747

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a class II major histocompatibility complex (MHC)-restricted, T-cell-mediated, demyelinating autoimmune disease of the central nervous system and represents a model for human multiple sclerosis. The present study demonstrates that vaccination of SJL/J mice with an 18-amino acid synthetic peptide from the third hypervariable region of the murine class II MHC IAs beta chain (IAs beta 58-75; 18-mer peptide) is capable of eliciting auto-anti-IAs antibodies specific for the IAs beta chain and preventing and treating EAE. A similar approach may be useful in the treatment of human autoimmune diseases in which susceptibility is linked to class II MHC genes.

Full text

PDF
8005

Images in this article

8007Image
on p.8007

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrawal B., Manickasundari M., Fraga E., Singh B. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice. J Immunol. 1991 Jul 15;147(2):383–390. [PubMed] [Google Scholar]
  2. Bell J. I., Denney D., Jr, Foster L., Belt T., Todd J. A., McDevitt H. O. Allelic variation in the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6234–6238. doi: 10.1073/pnas.84.17.6234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bell J. I., Denny D. W., Jr, McDevitt H. O. Structure and polymorphism of murine and human class II major histocompatibility antigens. Immunol Rev. 1985 Jul;84:51–71. doi: 10.1111/j.1600-065x.1985.tb01125.x. [DOI] [PubMed] [Google Scholar]
  4. Benichou G., Takizawa P. A., Ho P. T., Killion C. C., Olson C. A., McMillan M., Sercarz E. E. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J Exp Med. 1990 Nov 1;172(5):1341–1346. doi: 10.1084/jem.172.5.1341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brozek C. M., Hoffman C. L., Savage S. M., Searles R. P. Systemic lupus erythematosus sera inhibit antigen presentation by macrophages to T cells. Clin Immunol Immunopathol. 1988 Feb;46(2):299–313. doi: 10.1016/0090-1229(88)90192-4. [DOI] [PubMed] [Google Scholar]
  6. Edwards B. S., Searles R. P., Brozek C. M., Richards R., Savage S. M., Nolla H., Hoffman C. L. Isotype and cytotoxicity spectra of anti-lymphocyte antibodies in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1987 Dec;45(3):333–347. doi: 10.1016/0090-1229(87)90086-9. [DOI] [PubMed] [Google Scholar]
  7. Estess P., Begovich A. B., Koo M., Jones P. P., McDevitt H. O. Sequence analysis and structure-function correlations of murine q, k, u, s, and f haplotype I-A beta cDNA clones. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3594–3598. doi: 10.1073/pnas.83.11.3594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gammon G., Sercarz E. E., Benichou G. The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. Immunol Today. 1991 Jun;12(6):193–195. doi: 10.1016/0167-5699(91)90052-U. [DOI] [PubMed] [Google Scholar]
  9. Lider O., Reshef T., Beraud E., Ben-Nun A., Cohen I. R. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science. 1988 Jan 8;239(4836):181–183. doi: 10.1126/science.2447648. [DOI] [PubMed] [Google Scholar]
  10. Martin R., Howell M. D., Jaraquemada D., Flerlage M., Richert J., Brostoff S., Long E. O., McFarlin D. E., McFarland H. F. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med. 1991 Jan 1;173(1):19–24. doi: 10.1084/jem.173.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Martin R., McFarland H. F., McFarlin D. E. Immunological aspects of demyelinating diseases. Annu Rev Immunol. 1992;10:153–187. doi: 10.1146/annurev.iy.10.040192.001101. [DOI] [PubMed] [Google Scholar]
  12. Maryanski J. L., Pala P., Corradin G., Jordan B. R., Cerottini J. C. H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature. 1986 Dec 11;324(6097):578–579. doi: 10.1038/324578a0. [DOI] [PubMed] [Google Scholar]
  13. Morel P. A., Horn G. T., Budd R. C., Erlich H. A., Fathman C. G. Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritis. Hum Immunol. 1990 Feb;27(2):90–99. doi: 10.1016/0198-8859(90)90106-y. [DOI] [PubMed] [Google Scholar]
  14. Nag B., Deshpande S. V., Clark B. R. Novel methods to rapidly and sensitively analyze antigenic peptide binding to MHC class II molecules. J Immunol Methods. 1991 Aug 28;142(1):105–111. doi: 10.1016/0022-1759(91)90297-s. [DOI] [PubMed] [Google Scholar]
  15. Nag B., Passmore D., Deshpande S. V., Clark B. R. In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment. J Immunol. 1992 Jan 15;148(2):369–372. [PubMed] [Google Scholar]
  16. Nag B., Wada H. G., Passmore D., Clark B. R., Sharma S. D., McConnell H. M. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells. J Immunol. 1993 Feb 15;150(4):1358–1364. [PubMed] [Google Scholar]
  17. Nepom G. T., Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol. 1991;9:493–525. doi: 10.1146/annurev.iy.09.040191.002425. [DOI] [PubMed] [Google Scholar]
  18. Okudaira K., Goodwin J. S., Williams R. C., Jr Anti-Ia antibody in the sera of normal subjects after in vivo antigenic stimulation. J Exp Med. 1982 Jul 1;156(1):255–267. doi: 10.1084/jem.156.1.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ota K., Matsui M., Milford E. L., Mackin G. A., Weiner H. L., Hafler D. A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 1990 Jul 12;346(6280):183–187. doi: 10.1038/346183a0. [DOI] [PubMed] [Google Scholar]
  20. Pette M., Fujita K., Wilkinson D., Altmann D. M., Trowsdale J., Giegerich G., Hinkkanen A., Epplen J. T., Kappos L., Wekerle H. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci U S A. 1990 Oct;87(20):7968–7972. doi: 10.1073/pnas.87.20.7968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Savage S. M., Searles R. P., Troup G. M., Brozek C. M. Anti-idiotypic antibodies to anti-DR in patients with rheumatoid arthritis. Clin Immunol Immunopathol. 1987 Feb;42(2):183–194. doi: 10.1016/0090-1229(87)90005-5. [DOI] [PubMed] [Google Scholar]
  22. Schwartz R. H. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol. 1985;3:237–261. doi: 10.1146/annurev.iy.03.040185.001321. [DOI] [PubMed] [Google Scholar]
  23. Searles R. P., Savage S. M., Brozek C. M., Marnell L. L., Hoffman C. L. Network regulation in rheumatoid arthritis. Studies of DR+ T cells, anti-DR, antiidiotypic antibodies, and clinical disease activity. Arthritis Rheum. 1988 Jul;31(7):834–843. doi: 10.1002/art.1780310703. [DOI] [PubMed] [Google Scholar]
  24. Sharma S. D., Nag B., Su X. M., Green D., Spack E., Clark B. R., Sriram S. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11465–11469. doi: 10.1073/pnas.88.24.11465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sriram S., Roberts C. A. Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies. J Immunol. 1986 Jun 15;136(12):4464–4469. [PubMed] [Google Scholar]
  26. Sriram S., Steinman L. Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes. J Exp Med. 1983 Oct 1;158(4):1362–1367. doi: 10.1084/jem.158.4.1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sriram S., Topham D. J., Carroll L. Haplotype-specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies. J Immunol. 1987 Sep 1;139(5):1485–1489. [PubMed] [Google Scholar]
  28. Steinman L. Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire. Springer Semin Immunopathol. 1992;14(1):79–93. doi: 10.1007/BF00197133. [DOI] [PubMed] [Google Scholar]
  29. Steinman L., Rosenbaum J. T., Sriram S., McDevitt H. O. In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7111–7114. doi: 10.1073/pnas.78.11.7111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Todd J. A., Acha-Orbea H., Bell J. I., Chao N., Fronek Z., Jacob C. O., McDermott M., Sinha A. A., Timmerman L., Steinman L. A molecular basis for MHC class II--associated autoimmunity. Science. 1988 May 20;240(4855):1003–1009. doi: 10.1126/science.3368786. [DOI] [PubMed] [Google Scholar]
  31. Usuku K., Joshi N., Hauser S. L. T-cell receptors: germline polymorphism and patterns of usage in demyelinating diseases. Crit Rev Immunol. 1992;11(6):381–393. [PubMed] [Google Scholar]
  32. Vandenbark A. A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 1989 Oct 12;341(6242):541–544. doi: 10.1038/341541a0. [DOI] [PubMed] [Google Scholar]
  33. Wraith D. C., McDevitt H. O., Steinman L., Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell. 1989 Jun 2;57(5):709–715. doi: 10.1016/0092-8674(89)90786-1. [DOI] [PubMed] [Google Scholar]
  34. Zamvil S. S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol. 1990;8:579–621. doi: 10.1146/annurev.iy.08.040190.003051. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES